Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Net Income (2020 - 2025)

Bioventus' Net Income history spans 5 years, with the latest figure at $17.3 million for Q4 2025.

  • For Q4 2025, Net Income changed N/A year-over-year to $17.3 million; the TTM value through Dec 2025 reached $27.3 million, changed N/A, while the annual FY2023 figure was -$74.4 million, 8.28% down from the prior year.
  • Net Income reached $17.3 million in Q4 2025 per BVS's latest filing, up from $4.0 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $24.5 million in Q2 2021 to a low of -$74.4 million in Q2 2023.
  • Average Net Income over 4 years is -$8.0 million, with a median of -$401000.0 recorded in 2022.
  • Peak YoY movement for Net Income: surged 133.91% in 2021, then crashed 93484.0% in 2022.
  • A 4-year view of Net Income shows it stood at -$25000.0 in 2021, then plummeted by 93484.0% to -$23.4 million in 2022, then tumbled by 218.13% to -$74.4 million in 2023, then surged by 123.27% to $17.3 million in 2025.
  • Per Business Quant, the three most recent readings for BVS's Net Income are $17.3 million (Q4 2025), $4.0 million (Q3 2025), and $9.3 million (Q2 2025).